Peter B. F. Bergqvist

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

Connie Sánchez, Peter B. F. Bergqvist, Lise T. Brennum et al. · Psychopharmacology · 2003 · 265 citations

Psychiatry, Medicine, Psychotropic Medication +11

One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort® Turbuhaler®) for the treatment of asthma

L Rosenhall, A. ELVSTRAND, Björn Tilling et al. · Respiratory Medicine · 2003 · 80 citations · Full text

Asthma, Pulmonary Care, Allergy +9

Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder

Peter B. F. Bergqvist, Claude Bouchard, Pierre Blier · Biological Psychiatry · 1999 · 71 citations

Psychopathology, Brain Regions, Psychiatry +12

Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide

Malcolm D. Mason, Xavier Maldonado, Christopher P. Steidle et al. · Clinical Oncology · 2012 · 68 citations

Urology, Oncology, High-risk Prostate Cancer +5

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

H. J. van der Woude, Martin Boorsma, Peter B. F. Bergqvist et al. · Pulmonary Pharmacology & Therapeutics · 2003 · 62 citations

Asthma, Respiratory Diseases, Medicine +6